Invesco Nasdaq Biotechnology ETF (IBBQ)
|Ex-Dividend Date||Sep 19, 2022|
|Day's Range||19.48 - 19.68|
|Inception Date||Jun 11, 2021|
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Top 10 Holdings51.45% of assets
Biotech has had a strong rally since June, when fortune for the sector abruptly pivoted after months of underperformance. The sector peaked in early 2021 but struggled to continue the momentum, despit...
Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in its...
Earlier this week, Pfizer (NYSE:PFE) announced plans to acquire Biohaven Pharmaceutical (NASDAQ:BHVN) for $11.6 billion, sparking hopes of more biotechnology consolidation activity to come. Pfizer is pa...
After disappointing in 2021, biotechnology stocks and exchange traded funds are getting shellacked this year as growth stocks fall out of favor due to rising interest rates. As experienced biotech inves...
Although biotechnology stocks have been lackluster for the past year, the industry is gaining increased attention of late, not just for the role it's played in combatting the COVID-19 pandemic, but also...
Innovative biotechnology companies are coming out with novel treatments in the healthcare industry. Investors can also capture the ongoing innovations in the biotech sector through a targeted exchange t...
As is now widely documented, biotechnology stocks and exchange traded funds endured a rough 2021. Compounding those woes is the fact that investors were caught off guard by last year's lethargy because ...
The biotechnology industry is often a hotbed of mergers and acquisitions speculation. Announced deals are a different matter altogether.
Moderna (NasdaqGS: MRNA) jumped on Monday after announcing that a higher dosage booster of its vaccine could help mitigate COVID-19 Omicron risks before a tailor-made shot is finalized, lifting biotechn...
Broadly speaking, 2021 hasn't been kind to biotechnology stocks and exchange traded funds, but some market participants remain optimistic regarding a rebound for these previously beloved assets. One way...
While Covid-19 variants on the rise, the push for more vaccinations make the Invesco Nasdaq Biotechnology ETF (IBBQ) an ETF to watch. As Covid cases experience a resurgence, more companies are mandating...
The Invesco Nasdaq Biotechnology ETF (IBBQ) is just a few weeks old, but even with that rookie status, it could be a stellar second half idea. On the back of the Food and Drug Administration (FDA) condi...
As investors consider the regulatory, scientific, and demographic factors driving today's growth in biotechnology industry, they can look to the Nasdaq Biotechnology Index's methodology and one related ...
The Nasdaq Biotechnology Index (NBI) launched in 1993, when the industry was still in the midst of the original “biotech revolution.” Since then, its constituent basket has swelled from roughly 100 comp...